Does co-morbidity affect HIV risk reduction outcomes among women substance abusers in the southeast United States?
ISSUES: Although the incidence of AIDS is leveling out among most risk groups in the United States, it is still escalating among substance-abusing minority women. However, HIV-prevention campaigns targeting substance abusers have typically not provided interventions specific to women’s patterns of HIV risk and sexual behavior related to HIV transmission and have not addressed the co-morbid conditions typical among women. PROJECT: African American women street addicts (n = 264) in the southeast United States were enrolled in an intervention research project funded by the National Institute on Drug Abuse to reduce HIV risk behaviors. The study provided a brief intervention (including testing for HIV antibodies and pre- and post-test counseling) to address both drug and sexual risk behaviors. Risk behaviors and co-morbid conditions were assessed at intake and at 3-month follow-up. RESULTS: Using Ward’s method of cluster analysis for clinical symptoms of distress (physical health, depressi
Related Questions
- Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome?
- Does co-morbidity affect HIV risk reduction outcomes among women substance abusers in the southeast United States?
- Do perceptions of risk and quality of life affect use of hormone replacement therapy by postmenopausal women?
